This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Hybrid Event | 23 - 25 May 2023
Steigenberger Wiltcher's, Brussels

Georgia Gavriilidou
Associate General Counsel at Amgen


I am currently holding the position of the Associate General Counsel (Executive Director) at Amgen coordination the legal strategy on European Level on legal regulatory topics (including medicinal devices, pharmacovigilance, combination products, etc), market access and litigation. In my former role at the EMA, I was the lead lawyer in the implementation of major pharmaceutical legislation including the advanced therapies legislation and pharmacovigilance legislation. I have also served as chief legal adviser on a wide array of pharmaceutical issues relating to fixed-dose combination medicinal products, orphan and pediatric medicinal products, parallel distribution, invented names and validation/pre-authorization issues. My experience also covers counseling clients on life-cycle management of bio/pharma medicinal products, including the maximization of IP regulatory rights and representing clients on legal strategy before the National / EU Authorities, the UK and EU Courts (for EMA and clients).

Agenda Sessions

  • KEYNOTE PANEL: Detailed Review of Proposals for Incentivising R&D in Unmet Medical Needs: General Pharmaceutical Legislation, Orphan, and Paediatric Regulations